In NSCLC, KRAS mutations are seen in about 30% of lung adenocarcinomas and 5% of squamous lung cancers, in 26% of Westerners and 11% of Asians, and also in 30% of smokers and 10% of nonsmokers [22]. This evidence concerns the gene KRAS and lung adenocarcinoma.